Carolina Liquid Chemistries Corp. (CLC), an ISO-certified and FDA-regulated re-packager/re-labeler of chemistry systems, announced this week that its new Hemoglobin A1c (HbA1c) test, used on the CLC720 chemistry analyzer, has received certification by the National Glycohemoglobin Standardization Program (NGSP).
“Our test correlates to the NGSP certified tests used in large-scale diabetes studies,” says CLC Chief Operating Officer Patricia Shugart. “Physicians can now relate their HbA1c-direct results to these studies, providing more relevance.” She adds that features of HbA1c-direct include speed and ease of use, made possible by the company’s CLC720 chemistry analyzer, which automates the lysing step that would otherwise have to be performed manually.
Company representatives say that CLC specializes in innovative reagent technologies, developing user-friendly applications on clinical chemistry analyzers so that tests can be performed in physicians’ offices. The company offers a broad range of analyzers, from moderate throughput bench top analyzers to ultra high speed floor models, along with the reagents and service to support the instrumentation. Learn more about analyzers and reagents offered by Carolina Liquid Chemistries.
Read more
